Men's cancer screening knowledge targeted in new education trial
NCT ID NCT07087834
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a four-session education program called CASEM can improve men's perceptions, attitudes, and knowledge about cancer screening. Researchers will enroll 78 men in Turkey, split into an education group and a control group. The goal is to see if learning more leads to better screening habits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cancer Screenings Education for Men (CASEM) - a series of four weekly training sessions
- What this could lead to
- If successful, this education program could increase men's awareness and participation in cancer screening, potentially leading to earlier detection and better health outcomes.
- What could go wrong
- This is a small, early-stage study (78 men) measuring only knowledge and attitudes, not actual cancer rates. Results may not apply to other populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER SCREENING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pamukkale University
Denizli, 20160, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple online course boost cancer screening in migrant women?
- Phone nudges vs. cancer: can a simple app message save lives?
- Study seeks to improve cancer screening for transgender individuals before hysterectomy
- Personalized navigation may boost cancer screening in high-risk communities
- Web nurse program boosts cancer screening Know-How
- Texts and talks may boost cancer screening in women